PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,677,447 | trikoramid b bioactiv cyanobactin marin cyanobacterium symploca hydnoid three new cyanobactin trikoramid b isol marin cyanobacterium symploca hydnoid follow preliminari bioassay guid isol two activ polar fraction base brine shrimp toxic assay new cyanobactin new analogu previous report cytotox trikoramid differ main c ... | D000458 | T007 |
34,677,445 | marin oligocarrageenan inhibit migratori invas abil mda mb human breast cancer cell action heparanas metabol mmp mmp axi sugar base molecul heparin natur heparan sulfat polysaccharid develop wide studi control heparanas hpse enzymat activ key player extracellular matrix remodel cancer pathogenesi howev non enzymat func... | D000461 | T002 |
34,677,444 | fucosterol marin macroalga bioactiv safeti toxic organ fucosterol ethyliden cholesterol bioactiv compound belong sterol group isol marin alga fucosterol marin alga exhibit various biolog activ includ anti osteoarthrit anticanc anti inflammatori anti photoag immunomodulatori hepatoprotect anti neurolog antioxid algicid ... | D000975;D058086 | T044;T121;T123;T039;T204 |
34,677,443 | sp crus glycin rich region contribut larg antivir activ whole protein molecul interact vp wssv structur protein crustin cystein rich cation antimicrobi peptid divers biolog function includ antimicrobi proteinas inhibitori activ crustacean although crustin report respond white spot syndrom virus wssv infect detail antiv... | D003445 | T204 |
34,677,442 | efficaci chondroprotect food supplement base collagen hydrolys compound isol marin organ osteoarthr belong common joint diseas human anim show increas incid older patient bioactiv collagen hydrolys sulfat glucosamin special fatti acid enrich dog food test dog patient studi dog potenti therapeut treatment option earli o... | D019587 | T168;T061 |
34,677,441 | structur divers polycycl salicylaldehyd deriv enantiom marin deriv fungus eurotium sp scsio f enlarg chemic divers eurotium sp scsio f talent marin deriv fungus investig chemic constitu larg scale ferment modifi cultur four pair new salicylaldehyd deriv enantiom euroticin f well known one eurotirumin isol character com... | D055325 | T004 |
34,677,440 | cartilag acid protein novel therapeut factor improv skin damag repair fish skin gain attent due efficaci human wound treatment product identifi factor promot enhanc action skin fibroblast central role maintain skin integr secret extra cellular matrix ecm protein growth factor cytokin rapid repair lesion prevent damag i... | D015027 | T013 |
34,677,439 | combin anticanc effect sulfat laminaran brown alga alaria angusta polyhydroxysteroid glycosid starfish protoreast lincki colorect carcinoma hct cell line colorect cancer one frequent type malign world search new approach increas efficaci cancer therapi relev work aim studi individu combin anticanc effect molecular mech... | D000459;D013215 | T204 |
34,677,438 | protect effect ulva lactuca polysaccharid extract oxid stress kidney injuri induc galactos mice reactiv oxygen speci ros key factor caus mani diseas human bodi polysaccharid seawe shown signific antioxid activ vivo vitro amelior effect ulva lactuca polysaccharid extract upe renal injuri induc oxid stress analyz shown h... | D044445 | T002 |
34,677,437 | purif identif novel xanthin oxidas inhibitori peptid deriv round scad decapterus maruadsi protein hydrolys object present studi investig xanthin oxidas xo inhibitori effect peptid purifi identifi round scad decapterus maruadsi hydrolys rshs studi rshs obtain use three proteas neutras protamex alcalas among rshs h hydro... | D005399 | T013 |
34,677,436 | cyclopeptid deriv spong deriv fungus acremonium persicinum f cyclopeptid usual play pivot role either viabil virul fungi two type cyclopeptid six new hydroxam siderophor cyclohexapeptid includ acremonpeptid e f complex aluminum ferric ion one new cyclic pentapeptolid aselacin togeth known compound aselacin c isol chara... | D000164;D011161 | T004;T204 |
34,677,434 | dual target ptpb aldos reductas marin drug phosphoeleganin promis strategi treatment type diabet depth studi inhibitori mechan protein tyrosin phosphatas b ptpb aldos reductas ar enzym includ analysi insulin signal pathway phosphoeleganin marin deriv phosphoryl polyketid achiev phosphoeleganin demonstr inhibit enzym ac... | D014561 | T008;T204 |
34,677,432 | oncolyt vaccinia virus harbor aphrocallist vastus lectin inhibit growth cervic cancer cell hela aphrocallist vastus lectin avl c type marin lectin produc spong previous studi demonstr gene encod avl enhanc cytotox effect oncolyt vaccinia virus oncovv varieti cancer cell studi inhibitori effect oncovv avl hela cervic ca... | D011161 | T204 |
34,677,429 | anti inflammatori anticanc effect microalg carotenoid acut inflamm key compon immun system respons pathogen toxic agent tissu injuri involv stimul defens mechan aim remov pathogen factor restor tissu homeostasi howev uncontrol acut inflammatori respons may lead chronic inflamm involv develop mani diseas includ cancer n... | D058086 | T204 |
34,677,428 | anti inflammatori azaphilon edibl alga deriv fungus penicillium sclerotiorum discov new medic entiti edibl marin alga continu natur product investig focus endophyt marin macroalga grateloupia sp two new azaphilon epi hypocrellon epi eupenicilazaphilon c togeth five known azaphilon hypocrellon eupenicilazaphilon c e e d... | D058086;D010407 | T004;T204 |
34,677,427 | anti mycoplasma activ bacilotetrin c e cyclic lipodepsipeptid marin deriv bacillus subtili structur revis bacilotetrin b mycoplasma hyorhini common caus polyseros arthriti swine common contamin cell cultur laboratori continu research divers bioactiv compound bacillus subtili ggc discov uncommon cyclic lipotetrapeptid s... | D001412 | T007 |
34,677,361 | review capillari pressur control valv microfluid microfluid offer microenviron reagent deliveri handl mix reaction detect often demand affili equip liquid control function help tool capillari pressur control valv cpcv becom popular avoid use affili equip liquid handl control manner use bubbl pressur effect paper analyz... | D044085 | T090 |
34,677,360 | chronic studi brainwav authent real life set lstm base bag approach advent digit age concern secur author access sensit data increas besid tradit authent method interest biometr trait fingerprint iri facial characterist recent brainwav primarili base electroencephalographi eeg current work eeg base authent focus acut r... | D001699;D058256 | T062;T042 |
34,677,359 | biometr identif taxodium spp hybrid progeni electrochem fingerprint use electrochem fingerprint plant identif emerg applic biosensor work taxodium ascenden distichum mucronatum hybrid progeni collect purpos first attempt use electrochem fingerprint identif plant hybrid progeni electrochem fingerprint leav taxodium spp ... | D056667;D015374;D032489 | T066;T002;T059;T075 |
34,677,358 | enhanc plasmon biosensor util pair antibodi label free fe nanoparticl high sensit select detect parkinson synuclein serum parkinson diseas pd acut progress neurodegen disord diagnosi diseas earliest stage paramount import improv life expect patient synuclein syn potenti biomark earli diagnosi pd great need develop bios... | D015374;D053758;D010300 | T047;T059;T073;T075 |
34,677,357 | dielectrophoret electr imped differenti cancer cell base biophys phenotyp report studi detect electr character cancer cell line primari tumor cell dielectrophoresi dep electr imped spectroscopi ei joint employ enabl rapid label free differenti various cancer cell normal one primari tumor cell collect two colorect cance... | D058266;D007963 | T025;T059 |
34,677,356 | self referenc refract index biosens graphen fano reson mode hybrid structur compos period monolay graphen nanoribbon dielectr multilay structur design generat fano reson fr strong interact surfac plasmon reson graphen dielectr waveguid mode result fr finit element method util investig behavior fr match well theoret cal... | D015374;D006108;D037742 | T109;T073;T104;T196;T075;T059 |
34,677,355 | investig regul neural differenti injuri pc cell use microstructur topograph cue studi design manufactur seri differ microstructur topograph cue induc neuron differenti cell vitro differ topographi size structur complex cultur pc cell microstructur cue induc neural differenti use nerv growth factor ngf pheochromocytoma ... | D002454;D003463;D009474 | T043;T025;T078 |
34,677,354 | electr imped upper limb enabl robust wearabl ident recognit variat finger placement environment factor biometr authent technolog commerci various field main reli acquir imag structur inform fingerprint iris face howev bio recognit techniqu use exist physic featur alway risk templat forgeri threat fake fingerprint due r... | D000076251 | T073 |
34,677,353 | comput simul surfac charg nanobiosensor intern signal integr ioniz state molecular analyt locat solid surfac requir profound investig better understand applic basic scienc general design nanobiosensor particular ioniz state induc interact molecul analyz substanc target surfac comput simul use comsol multiphys softwar s... | D015374 | T059;T075 |
34,677,352 | malign biosensor focus oral cancer detect salivari biomark oral cancer among deadliest type malign due late stage usual diagnos leav patient averag five year surviv rate less boom field biosens point care diagnost regard play major role earli detect oral cancer saliva gain interest altern biofluid non invas diagnost ma... | D015374;D009062 | T191;T059;T075 |
34,677,351 | topograph vacuum seal print multiplanar microfluid structur demonstr novel way creat three dimension microfluid channel capabl follow complex topographi end substrat open channel differ geometri print open channel consecut close thermoplast use low resolut vacuum form approach process allow seal channel locat surfac co... | D044085;D054843 | T061;T074;T090 |
34,677,350 | liquid biopsi base biosensor mrd detect treatment monitor non small cell lung cancer nsclc global non small cell lung cancer nsclc lead caus cancer death despit advanc chemotherapi target therapi year surviv rate remain past forti year minim residu diseas mrd describ exist either isol tumour cell circul tumour cell bio... | D015374;D002289;D008175 | T191;T059;T075 |
34,677,349 | biomechan physiolog evalu multi joint exoskeleton activ passiv assist walk improv walk effici ensur wearabl import issu lower limb exoskeleton activ devic provid greater forc passiv devic advantag weight present multi joint exoskeleton activ hip extens assist passiv ankl plantarflexion assist work admitt control base f... | D000067190;D016138 | T074;T169;T056 |
34,677,348 | site detect carcinoembryon antigen human serum real time connect employ sustain materi empow point care diagnost capabl send clinic relev data health care provid even low resourc set studi develop advantag kit site detect carcinoembryon antigen cea human serum cea sens perform use cellulos base later flow strip colorim... | D015374 | T059;T075 |
34,677,347 | oxygen satur behavior puls oximetri femal athlet break myth myth surround women particip sport reflect respiratori physiolog studi aim demonstr continu monitor blood oxygen satur maxim exercis test femal athlet high correl determin second ventilatori threshold vt anaerob threshold ant measur perform use puls oximet max... | D010092;D010101;D000089382 | T059;T060;T201 |
34,677,346 | theoret model high sensit near infrar biosensor base bloch surfac wave dirac semimet work present theoret model near infrar sensit refract index biosensor base truncat photon crystal pc structur dirac semimet high sensit near infrar biosensor origin sharp reflect peak caus excit bloch surfac wave bsw interfac dirac sem... | D015374;D006108 | T109;T059;T196;T075 |
34,677,345 | brain comput interfac use function near infrar spectroscopi fnir function near infrar spectroscopi fnir wearabl optic spectroscopi system origin develop continu non invas monitor brain function measur blood oxygen concentr recent advanc brain comput interfac allow us control neuron function brain combin fnir regul cogn... | D001921;D019265 | T023;T059 |
34,677,344 | microfluid lab chip base uhf dielectrophoresi stem phenotyp character discrimin among glioblastoma cell glioblastoma gbm one aggress solid tumor particular due presenc cancer stem cell cscs nowaday character cell type effici fast low cost method remain issu henc develop microfluid lab chip base dielectrophoresi dep sin... | D004586;D005909;D056656 | T191;T059;T075 |
34,677,343 | noncontact optic measur aqueous humor glucos level correl serum glucos level rabbit noninvas measur serum glucos level investig monitor blood sugar control diabet studi aim develop novel noncontact glucomet ncgm util optic approach measur intraocular aqueous humor glucos level anterior chamber rabbit eye ncgm consist h... | D001082;D003920 | T039;T047;T031 |
34,677,341 | applic microfluid liquid crystal base biosensor liquid crystal lcs stimuli respons configur transit optic anisotrop properti attract enorm interest develop simpl label free biosensor combin microfluid lcs offer great advantag tradit lc base biosensor includ small sampl consumpt fast analysi low cost moreov microfluid t... | D015374;D050866;D044085 | T073;T104;T075;T059;T090 |
34,677,340 | applic function graphen oxid base biosensor health monitor simpl graphen deriv print platform biosensor hold great potenti revolution person medicin environment monitor construct key factor depend either manufactur techniqu robust sens materi improv efficaci devic function graphen attract choic transduc materi due vari... | D015374;D006108;D066330 | T109;T073;T196;T075;T059 |
34,677,339 | fibr optic surfac plasmon reson biosensor monoclon antibodi titer quantif extraordinari optic transmiss fibr optic surfac plasmon reson biosens platform engin improv portabl sensit appli monitor concentr monoclon antibodi mab refin fabric procedur chang materi flow cell compon optic fibr biosensor portabl robust extern... | D015374;D020349 | T059;T063;T075 |
34,677,338 | nanozym particip biosens pesticid cholinesteras critic review improv output qualiti agricultur product pesticid global util effici tool protect crop insect howev given pesticid use difficult decompos inevit remain agricultur product enrich food chain ecosystem pose great threat human health environ thus develop effici ... | D015374;D002802;D049329;D010575 | T116;T073;T131;T075;T059;T126 |
34,677,337 | smartphon base chemiluminesc origami pad rapid assess glucos blood level microfluid paper analyt devic pad repres one appeal trend develop simpl inexpens analyt system diagnost applic point care poc herein describ smartphon base origami pad quantit determin glucos blood sampl base glucos oxidas catalyz oxid glucos lead... | D056656;D008163;D000068997 | T059;T073;T075 |
34,677,336 | mesopor one compon gold microshel ser substrat surfac enhanc raman scatter ser power analyt tool label free analysi found broad spectrum applic materi chemic biomed scienc recent year great interest wit ration design ser substrat amplifi raman signal option allow select detect analyt especi essenti challeng biomed appl... | D006046;D053768 | T121;T073;T196 |
34,677,335 | algin bead biosystem determin lactat sweat use imag analysi lactat present sweat high concentr metabolit high interest sport scienc medicin therefor potenti determin lactat concentr physiolog fluid point need minim invas valuabl work synthesi perform algin bead biosystem investig artifici sweat differ lactat concentr u... | D019344;D013542 | T031;T121;T109;T123 |
34,677,334 | aptam embed arch cruciform dna assembl vs scaffold sensit detect breast cancer cell arch cruciform dna self assembl aunpsv scaffold high sensit select electrochem biosensor michigan cancer foundat mcf breast cancer cell construct arch dna form use two singl strand dna sequenc embed aptam mcf cell absenc mcf cell crucif... | D052157;D015374;D001943;D053768 | T191;T073;T114;T075;T059 |
34,677,333 | high sensit terahertz biosensor base mode coupl graphenebragg reflector hybrid structur work high sensit terahertz thz biosensor achiev use graphenebragg reflector hybrid structur high sensit thz biosensor develop sharp fano reson transmiss peak creat coupl graphen tamm plasmon gtps mode defect mode found propos thz bi... | D015374;D006108 | T109;T059;T196;T075 |
34,677,332 | design analysi singl system impedimetr biosensor detect mosquito born virus treatment mosquito born viral diseas dengu virus denv zika virus zikv chikungunya virus chikv becom difficult due delay diagnosi process addit share transmiss media similar symptom earli stage infect diseas becom critic earli diagnosi overcom c... | D015374;D065632;D002646;D009033;D003715;D003716;D000079426;D000071244;D000071243 | T047;T005;T204;T075;T059 |
34,677,331 | paper base airborn bacteria collect dna extract kit critic risk airborn infecti diseas bio weapon harm bacteria current highest ever human histori requir monitor airborn pathogen gradual increas defend bioterror prevent pandem especi via simpl low cost platform appli resourc limit set develop paper base airborn bacteri... | D000391;D001419;D004269 | T007;T114;T067 |
34,677,330 | singl substrat biosensor spin coat liquid crystal film simpl sensit label free protein detect liquid crystal lc base singl substrat biosensor develop spin coat lc thin film dimethyloctadecyl trimethoxysilyl propyl ammonium chlorid dmoap decor glass slide compar convent sandwich cell configur simplifi procedur prepar lc... | D015374;D050866 | T059;T104;T073;T075 |
34,677,328 | recent advanc iot assist wearabl sensor system healthcar monitor iot play essenti role mani industri last decad recent advanc healthcar industri made possibl make healthcar access peopl improv overal health next step healthcar integr iot assist wearabl sensor system seamless review rigor discuss various iot architectur... | D000076251 | T073 |
34,677,327 | versatil cell anim model advanc investig lead poison heavi metal lead pb irrevers damag human nervous system help understand pb induc damag appli genet encod frster reson energi transfer fret base pb biosensor met lead two live system monitor concentr pb induc pluripot stem cell ipsc deriv cardiomyocyt semi tissu platf... | D015374;D007855 | T059;T037;T075 |
34,677,326 | sub part per billion level sens fentanyl residu wastewat use portabl surfac enhanc raman scatter sens detect illicit drug residu wastewat provid new rout toward communiti level assess drug abus critic public health howev tradit chemistri analyt tool high perform liquid chromatographi tandem mass spectrometri hplc ms me... | D005283;D053768 | T121;T073;T109 |
34,677,324 | dispos voltammetr sensor modifi block copolym dispers graphen simultan determin dopamin ascorb acid ex vivo mous brain tissu dopamin da ascorb acid aa two import biomark similar oxid potenti facilit simultan electrochem detect new voltammetr sensor develop modifi screen print carbon electrod spce newli synthes block co... | D001921 | T023 |
34,677,323 | optic biosensor platform display vari sensit direct detect influenza rna detect method requir nucleic acid amplif advantag viral diagnost due rapid result platform could provid inform accur diagnos pandem surveil influenza virus prone pandem induc genet mutat need appli detect platform influenza diagnost analyz fast ev... | D007251;D021141 | T047;T059;T063 |
34,677,322 | fpga base machin learn tool situ food qualiti track use sensor fusion continu develop accur select bio chemo sensor led grow use sensor array differ field health monitor cell cultur analysi bio signal process food qualiti track analysi inform extract amount data provid sensor array possibl base machin learn techniqu ap... | D005504;D012815 | T059;T066 |
34,677,321 | distinguish amyloid protein mous model alzheim diseas label free vibrat imag due increas averag age human alzheim diseas ad becom one disord highest incid worldwid abnorm amyloid protein accumul believ common caus ad therefor distinguish lesion area provid clue ad diagnosi present optic spectroscopi imag approach base ... | D000544 | T048;T047 |
34,677,320 | advanc nanotechnolog base biosens immunoregulatori cytokin cytokin larg group small protein secret immun non immun cell respons extern stimuli much attent given applic cytokin detect earli diseas diagnosismonitor therapeut respons assess date wide rang assay avail cytokin detect howev specif applic multiplex continu me... | D015374;D016207 | T129;T059;T116;T075 |
34,677,319 | optic smartphon base inspect platform identif diseas orchid infect orchid odontoglossum ringspot virus cymbidium mosaic virus caus orchid disfigur substanti sourc econom loss orchid farm although immunoassay identifi infect immunoassay expens time consum labor consum limit sampl base test method studi propos noncontact... | D029595;D000068997 | T002;T073 |
34,677,318 | surfac plasmon reson proteas detect integr homogen reaction heterogen assay proteas usual requir immobil peptid substrat solid surfac enzymat hydrolysi reaction howev immobil peptid solid surfac may caus steric hindranc prevent interact substrat activ center proteas thus limit enzymat cleavag peptid work report heterog... | D020349 | T063 |
34,677,317 | novel micro nano optoelectron biosensor label free real time biofilm monitor accord world health organ forecast antimicrobi resist amr expect becom one lead caus death worldwid follow decad rise danger amr caus overus antibiot becom ineffect mani pathogen particular presenc bacteri biofilm context non destruct label fr... | D018441;D015374;D004784 | T007;T059;T057;T075 |
34,677,316 | recent progress electrochem immunosensor biosensor use medic diagnosi work analyz physiolog fluid antibodi frequent use molecular recognit molecul specif bind target analyt complex biolog solut electrochemistri introduc measur quantit signal transduc bound analyt mani reason includ good sensit recent numer electrochem ... | D015374;D055664 | T059;T075 |
34,677,315 | nanosystem biosens prototyp effici diagnost special issu honor professor bansi malhotra proven rapid bioinformat analysi accord patient health profil addit biomark detect low level emerg essenti design analyt diagnost system manag health intellig person manner object need optim combin nano enabl sens prototyp artifici ... | D015374;D036103 | T059;T090;T075 |
34,677,314 | millimet wave base spoof local surfac plasmon reson sens glucos concentr glucos monitor sensor necessari extens studi prevent control health problem caus diabet spoof local surfac plasmon lsp reson sensor investig chemic sens biosens spoof lsp similar characterist lsp microwav terahertz frequenc rang certain advantag h... | D015374;D001786 | T059;T109;T075 |
34,677,313 | high sensit luminesc bioassay use recombin escherichia coli biosensor rapid detect low cr vi concentr environment water studi construct recombin escherichia coli strain differ promot insert chromat sens regul chrb report gene luxab sens low hexaval chromium cr vi concentr mgl subsequ biosensor characterist sensit selec... | D015374;D004784 | T059;T057;T075 |
34,677,311 | high perform passiv plasma separ ost pillar forest plasma separ high interest later flow test use whole blood sampl liquid built passiv microfluid devic plasma separ high perform devic made blood filtrat membran stoichiometri thiol ene ost pillar forest ost pillar forest fabric doubl replica mold laser cut polymethylme... | D056656;D046210 | T059;T075 |
34,677,310 | bio specif auf porous spongi nanoclust sensit ser detect escherichia coli h sensit fast detect escherichia coli h organ inorgan hybrid auf nanoclust ncs synthes first time use gold nanoparticl gnps bovin serum albumin ferric chlorid phosphat buffer salin antibodi auf porous spongi ncs larg surfac area show excel bio sp... | D055664;D019453;D005516 | T007;T059;T067 |
34,677,309 | determin particl size posit coplanar electrod setup use measur opac microfluid cytometri microfluid imped flow cytomet enabl high throughput non invas label free detect singl cell cytomet coplanar electrod easi cheap fabric sensit posit differ pass particl owe inhomogen electr field present novel particl height compens... | D046210 | T059 |
34,677,308 | roll circl amplif effici analyt tool rapid detect contamin aqueous environ environment contamin global concern effect strategi remedi develop rapid site afford monitor method howev remain challeng especi regard detect various contamin complex water environ applic molecular method recent attract increas attent exampl ro... | D004784 | T057 |
34,677,306 | mitig data packet loss bluetooth low energi base wearabl healthcar ecosystem bluetooth low energi ble play critic role wireless data transmiss wearabl technolog previous work field most focus optim transmiss throughput power consumpt howev much work report systemat evalu data packet loss ble wearabl healthcar ecosystem... | D003695;D059015 | T058;T093;T073 |
34,677,277 | oment macrophag crown like structur associ poor prognosi advanc stage serous ovarian cancer tumor microenviron well recogn framework immun cell present tumor microenviron promot inhibit cancer format develop crown like structur cls report die dead adipocyt surround crown macrophag within adipos tissu histolog hallmark ... | D009852;D010051 | T191;T023 |
34,677,276 | total colectomi part ultra radic surgeri ovarian cancer short long term outcom background aim studi assess outcom patient underw total colectomi tc part surgeri ovarian cancer oc method perform retrospect analysi oc patient residu diseas rd report use sugarbak complet cytoreduct score result forti two patient underw tc... | D020360;D010051 | T191;T061 |
34,677,275 | effect safeti first line pembrolizumab older adult pd l posit non small cell lung cancer retrospect cohort studi alberta immunotherapi databas emerg immunotherapi revolution treatment non small cell lung cancer nsclc multipl landmark clinic trial establish efficaci agent howev mani patient receiv immunotherapi clinic p... | D002289;D008175 | T191 |
34,677,274 | chang health state util valu japanes patient end stage breast cancer aim determin dynam trend health state util valu hsuv patient end stage breast cancer select patient compris primari breast cancer pbc metastat breast cancer mbc survivor patient mbc death hsuv patient pbc mbc survivor month respect end observ period v... | D001943 | T191 |
34,677,273 | heart emot consequ conceptu caregiv report outcom context colorect cancer colorect cancer crc demand primari caregiv yet insuffici evid describ caregiv report outcom cros matter caregiv cros refer caregiv assess health status result support patient studi purpos describ emot impact caregiv patient crc import caregiv att... | D017028;D015179 | T097;T191;T098;T099 |
34,677,272 | consider develop reassess process report canadian real world evid valu cancer drug canrevalu collabor reassess uptak work group canadian real world evid valu cancer drug canrevalu collabor establish develop framework generat use real world evid rwe inform reassess cancer drug follow initi health technolog assess hta re... | D000970;D009369 | T191;T121;T109 |
34,677,271 | singl center comparison cu dotaga psma f psma pet ct imag prostat cancer diagnost perform cu dotaga psma pet ct imag compar retrospect f psma pet ct prostat cancer patient recurr diseas primari stage select patient advanc local possibl metastat diseas | D000072078;D011471 | T191;T060 |
34,677,270 | pretreat neutrophil lymphocyt ratio predict marker respons atezolizumab plus bevacizumab hepatocellular carcinoma combin therapi anti program death ligand monoclon antibodi atezolizumab plus anti vascular endotheli growth factor agent bevacizumab atezobev approv first line treatment unresect hepatocellular carcinoma hc... | D006528;D008113 | T191 |
34,677,269 | exercis reduc anthracyclin mediat cardiovascular complic breast cancer survivor develop cancer therapeut great reduc morbid mortal femal breast cancer come cost increas risk cardiovascular complic particular anthracyclin like doxorubicin mainstay current chemotherapi regimen associ dose depend cardiotox exercis wide ac... | D001943;D000073116;D006331 | T191;T047;T101;T201 |
34,677,268 | neoadjuv therapi lung cancer import object respons rate major patholog respons lung cancer fatal frequent diagnos malign tumor neoadjuv therapi promis approach prolong surviv increas chanc cure rate patient potenti resect diseas current mani therapeut altern includ chemotherapi target therapi immunotherapi continu expl... | D002289;D008175 | T191 |
34,677,267 | impact split dose first rituximab infus patient high lymphocyt count common advers reaction rituximab infus relat reaction irr evalu efficaci split dose first rituximab infus two day reduc irr incid patient hematolog cancer high lymphocyt count retrospect observ studi conduct two healthcar center quebec canada studi en... | D000069283 | T129;T121;T116 |
34,677,266 | incid etiolog prevent manag ureteroenter strictur robot assist radic cystectomi review publish evid person experi benign ureteroenter anastomosi strictur uess one mani critic complic may caus irrevers disabl follow robot assist radic cystectomi rarc previous studi shown incid rate ue rarc reach rarc higher ue incid rat... | D012371;D014513;D001749 | T191;T023;T090 |
34,677,265 | immunotherapi extens stage small cell lung cancer small cell lung cancer sclc remain poor understood diseas aggress featur high relaps rate signific morbid well mortal yet persist limit treatment option three decad treatment algorithm sclc stagnant despit multipl attempt find altern therapeut option could improv respon... | D008175;D055752 | T191 |
34,677,264 | synaptotagmin high express estrogen receptor posit breast cancer accumul evid indic tumor promot role synaptotagmin syt sever cancer howev studi investig express breast cancer bc studi aim clarifi signific syt bc | D001943;D011960 | T192;T191;T116 |
34,677,263 | recent advanc photodynam imag therapi hepatobiliari malign clinic experiment aspect therapeut diagnost modal light well known deriv photodynam reaction photosensit pss specif wavelength light exposur exist tissu oxygen develop sinc th centuri photodynam therapi pdt effect local treatment cancer specif laser ablat malig... | D001650;D018281 | T191 |
34,677,262 | breast cancer surgeri new issu sinc ancient time breast cancer treatment crucial reli surgeon clinician make great effort find increas conserv approach cure tumor halstedian era mid late th centuri predomin practic consist radic disfigur remov breast much detriment women psycho physic well thank enlighten scientist pro... | D001943 | T191 |
34,677,261 | examin pathoplast moder role educ associ depress mood self rate health among cancer survivor popul base studi self rate health srh salient patient outcom cancer survivor depress mood educ known determin cancer survivor srh move beyond well establish direct associ depress mood educ srh among cancer survivor epidemiolog ... | D000073116;D009369 | T191;T101;T201 |
34,677,260 | influenc adjuv chemotherapi dose intens five year outcom resect colon cancer singl centr retrospect analysi evid achiev dose intens adjuv colon cancer treatment improv surviv total consecut patient resect stage iii high risk stage ii colon cancer receiv adjuv chemotherapi retrospect analyz patient receiv least week adj... | D003110;D009944 | T191;T109 |
34,677,259 | multifoc multicentr breast cancer comparison effici mammographi contrast enhanc spectral mammographi magnet reson imag group patient primarili oper breast cancer multifoc multicentr breast cancer mfmcc signific aspect determin specialist choic appli breast conserv therapi bct perform mastectomi studi aim assess use mam... | D001943 | T191 |
34,677,258 | role navig radiofrequ ablat devic concurr vertebr augment treatment difficult reach spinal metastas purpos studi assess effect navig radiofrequ ablat devic concurr vertebr augment treatment posterior vertebr bodi metastat lesion technic difficult access primari outcom studi evalu pain palliat radiolog assess local tumo... | D017115;D000078703;D013125 | T191;T061 |
34,677,257 | cognit assess tool recommend geriatr oncolog guidelin rapid review cognit assess cornerston geriatr care cognit impair potenti signific impact multipl phase person cancer care experi accur identifi vulner challeng mani cancer care clinician thus use valid cognit assess tool recommend intern cancer guidelin older adult ... | D060825;D009369 | T048;T191 |
34,677,256 | real world outcom patient advanc melanoma treat alberta canada time era base analysi immun checkpoint map kinas pathway inhibitor signific improv long term surviv patient melanoma limit real world data regimen effect retrospect analyz patient unresect metastat melanoma august juli treat immun checkpoint inhibitor map k... | D008545 | T191 |
34,677,255 | rethink clinic trial react program canadian led pragmat trial program strategi integr knowledg user trial design review patient health care provid hcp survey perform react program react team perform patient survey respond hcp survey respond address broad rang topic breast cancer manag time proport survey distribut pape... | D000086382;D058873 | T047;T067 |
34,677,254 | combin exoscop endoscop techniqu craniofaci resect determin feasibl combin exoscop endoscop techniqu cee altern microscop craniofaci resect cfr retrospect studi conduct singl institut includ eight consecut patient head neck tumor underw cfr septemb juli transcrani approach microsurgeri perform use exoscop manner tradit... | D004724;D019291 | T029;T060 |
34,677,253 | intraop radiotherapi balloon base electron brachytherapi system systemat review first bulgarian experi breast cancer patient background aim analyz current avail studi intraop radiotherapi iort choic treatment xoft axxent electron brachytherapi ebx system use singl dose irradi exclus radiotherapi approach time surgeri p... | D001918;D001943 | T191;T061 |
34,677,252 | psychosoci function predictor mental disord among prostat cancer survivor inform survivorship care program evid base knowledg recent research reveal prostat cancer pca survivor face silent epidem mental disord find surpris side effect high effect current treatment modal consid assess associ urinari function qualiti lif... | D000073116;D001523;D011471 | T048;T191;T101;T201 |
34,677,251 | treatment regret mental physic health indic psychosoci well among prostat cancer survivor prostat cancer pca patient survivor high risk mental health ill examin contribut treatment regret mental physic health indic socialfamili emot function spiritu well pca survivor studi assess men histori pca resid maritim canada su... | D000073116;D062645;D011471 | T061;T191;T101;T201 |
34,677,250 | spinal manifest malign primari plb secondari bone lymphoma slb manifest malign lymphoma spine rare case report literatur due rariti gold standard manag patient suffer spinal lymphoma manifest method retrospect review data patient femal male malign lymphoma spine receiv intervent center march june neurolog impair pain d... | D008223;D013904 | T191;T023 |
34,677,249 | prognost factor influenc surviv treatment pattern analysi convent palliat radiotherapi patient bone metastas treatment indic bone metastas influenc patient prognosi singl fraction radiotherapi sfrt proven equal effect multipl fraction regimen mfrt continu underus | D001859;D018787 | T091;T191 |
34,677,248 | challeng return work breast cancer role famili situat canto cohort return work rtw breast cancer associ improv qualiti life link household characterist rtw remain larg unknown aim studi examin effect famili situat women rtw two year breast cancer use data french prospect cohort women diagnos stage iii primari breast ca... | D001943;D062707 | T033;T191 |
34,677,247 | craft propos framework decentr clinic trial particip canada canada vast geographi central deliveri cancer care clinic trial creat barrier trial particip patient remot rural set develop implement framework enabl safe regulatori compliant trial particip local healthcar provid would benefit canadian patient clinician tria... | D017216 | T058 |
34,677,246 | prognost radiolog tool clinic stage ia pure solid lung cancer studi analyz prognost radiolog tool surgic outcom radiolog pure solid adenocarcinoma ad squamous cell carcinoma sq clinic stage ia retrospect investig patient underw surgic resect assess predict risk factor recurr patholog lymph node metastasi lnm statist di... | D019788;D008175 | T130;T191;T109 |
34,677,245 | express senesc apoptosi biomark synchron bilater breast cancer case report synchron bilater breast cancer sbbc provid special condit two independ breast tumor expos cancer pharmacotherapi within uniform pharmacokinet milieu senesc apoptosi establish respons therapi howev potenti variabl contribut overal outcom treatmen... | D001943;D009378 | T191 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.